Literature DB >> 9860884

Current approaches toward chemical mixture studies at the National Institute of Environmental Health Sciences and the U.S. National Toxicology Program.

J R Bucher1, G Lucier.   

Abstract

The National Institute of Environmental Health Sciences (NIEHS) has several new initiatives involving chemical mixtures and has recognized the need to develop new experimental approaches to enhance our efforts in this area. Responding to recent increases in nominations of complex occupational exposures for toxicologic assessment by the U.S. National Toxicology Program, the NIEHS and the National Institute for Occupational Safety and Health have begun a program to characterize exposures through field studies, identify biomarkers of exposure in workers, and recreate relevant mixed exposures in a laboratory setting. A second initiative with the National Center for Environmental Health/Centers for Disease Control and Prevention will examine blood samples from the U.S. National Health and Nutrition Examination Survey population surveys for selected endocrine-disrupting agents and for common patterns of persistent xenobiotics, providing critical information for the design of animal studies to assess risks of relevant chemical mixtures to humans. New toxicology testing methods (lower cost, faster) will enhance our ability to study chemical mixtures (e.g., dioxin and dioxinlike chemicals, combination AIDS therapies). Ongoing method development efforts involve in vitro functional toxicology assays, screens for estrogenic activity, and carcinogenesis studies in transgenic mice. A major scientific initiative with mixtures involves studies of individual and mixtures of dioxin and dioxinlike chemicals to determine if toxic equivalence factors predict carcinogenic potency in traditional and transgenic bioassays. Complementing these studies is an increased emphasis on physiologically based pharmacokinetic modeling, an activity central to the proper interpretation of chemical mixture studies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9860884      PMCID: PMC1533434          DOI: 10.1289/ehp.98106s61295

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  6 in total

1.  Synergistic signals in the environment.

Authors:  S F Arnold; J A McLachlan
Journal:  Environ Health Perspect       Date:  1996-10       Impact factor: 9.031

2.  Toxicology studies of a chemical mixture of 25 groundwater contaminants: hepatic and renal assessment, response to carbon tetrachloride challenge, and influence of treatment-induced water restriction.

Authors:  J E Simmons; R S Yang; D J Svendsgaard; M B Thompson; J C Seely; A McDonald
Journal:  J Toxicol Environ Health       Date:  1994-11

3.  Assessing environmental chemicals for estrogenicity using a combination of in vitro and in vivo assays.

Authors:  M D Shelby; R R Newbold; D B Tully; K Chae; V L Davis
Journal:  Environ Health Perspect       Date:  1996-12       Impact factor: 9.031

4.  Mechanism-based toxicology in cancer risk assessment: implications for research, regulation, and legislation.

Authors:  G W Lucier
Journal:  Environ Health Perspect       Date:  1996-01       Impact factor: 9.031

5.  Functional toxicology: a new approach to detect biologically active xenobiotics.

Authors:  J A McLachlan
Journal:  Environ Health Perspect       Date:  1993-10       Impact factor: 9.031

6.  Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models.

Authors:  R W Tennant; J E French; J W Spalding
Journal:  Environ Health Perspect       Date:  1995-10       Impact factor: 9.031

  6 in total
  2 in total

1.  Chemical mixtures: considering the evolution of toxicology and chemical assessment.

Authors:  Emily Monosson
Journal:  Environ Health Perspect       Date:  2005-04       Impact factor: 9.031

2.  The "new" genetics and mammalian cloning in environmental health research.

Authors:  P M Iannaccone
Journal:  Environ Health Perspect       Date:  2000-10       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.